Hi, what are you looking for?
– Teva confirmed that it will continue to vigorously defend its Copaxone intellectual property rights. – Please help us out : Will you offer us...
– Sales of the multiple sclerosis treatment were down 12% in the second quarter. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported...
– Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that all proposals were approved at its Annual General Meeting of Shareholders held earlier today. These proposals included...
– Barclays analyst Douglas Tsao sees the success of double-dose Copaxone as a platform for expansion. – “The mergers and acquisition phenomenon is one...
– According to a recent SEC filing, reported by Economic Policy Journal, the largest stake held by the George Soros Fund Management is a...
– Glass Lewis even recommends against board motions to which Benny Landa has not objected. A day after ISS recommended investors to support Teva...
See also: Teva Pharmaceuticals Denies Picking New Chairman – I am an industrialist, not a financial investor. I focus on running my own...
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced that the Company has filed a citizen petition (CP) regarding the approvability of purported generic versions of...
– The activist shareholder still fears that the Teva board won’t do what the company needs. – – “These are definitely steps in the...
– Chaim Hurvitz and Dan Suesskind will step down and Chairman Phillip Frost will leave before the end of the year. – – Chaim...